Published in HPB (Oxford) on November 19, 2012
Could metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease? World J Gastroenterol (2014) 0.99
Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases? HPB (Oxford) (2014) 0.97
Novel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and development. Int J Mol Sci (2014) 0.89
Body mass index and cholesterol level predict surgical outcome in patients with hepatocellular carcinoma in Taiwan - a cohort study. Oncotarget (2016) 0.86
Expression levels of insulin-like growth factors and receptors in hepatocellular carcinoma: a retrospective study. World J Surg Oncol (2014) 0.80
Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B. Clin Mol Hepatol (2016) 0.78
Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients. World J Gastroenterol (2016) 0.77
Recipient C6 rs9200 genotype is associated with hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population. Cancer Gene Ther (2016) 0.77
"Weighing the risk": Obesity and outcomes following liver transplantation. World J Hepatol (2015) 0.76
Obesity and Energy Balance in GI Cancer. J Clin Oncol (2016) 0.76
Obesity Does Not Influence Outcomes in Hepatocellular Carcinoma Patients following Curative Hepatectomy. PLoS One (2015) 0.75
The Role of Bariatric Surgery in Abdominal Organ Transplantation-the Next Big Challenge? Obes Surg (2017) 0.75
Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser (2000) 70.59
Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg (2004) 55.13
Prevalence and trends in obesity among US adults, 1999-2000. JAMA (2002) 33.23
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med (1996) 22.46
Estimating the world cancer burden: Globocan 2000. Int J Cancer (2001) 16.92
Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol (2009) 9.84
Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr (2006) 4.72
Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57
Leptin and cancer. J Cell Physiol (2006) 2.88
The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology (1997) 2.57
Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Res (2007) 2.50
Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States. Hepatology (2002) 1.98
The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transplant (2005) 1.90
The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time. J Clin Oncol (2003) 1.88
Adipose tissue: a regulator of inflammation. Best Pract Res Clin Endocrinol Metab (2005) 1.86
Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways. FASEB J (2000) 1.75
Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators. Arch Surg (2008) 1.65
Leptin signalling. Cell Signal (2002) 1.63
The impact of obesity on surgical outcomes: a review. J Am Coll Surg (1997) 1.53
Obesity and outcome following renal transplantation. Am J Transplant (2006) 1.46
Effect of race on outcome of orthotopic liver transplantation: a cohort study. Lancet (2002) 1.45
Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis. Hepatology (2010) 1.23
Surgical implications of obesity. Annu Rev Med (1998) 1.21
Pancreatic steatosis promotes dissemination and lethality of pancreatic cancer. J Am Coll Surg (2009) 1.18
Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway. Endocr Relat Cancer (2007) 1.17
The impact of recipient body mass index on survival after lung transplantation. J Heart Lung Transplant (2010) 1.13
A model to predict survival at one month, one year, and five years after liver transplantation based on pretransplant clinical characteristics. Liver Transpl (2003) 1.11
Postoperative morbidity, mortality, costs, and long-term survival in severely obese patients undergoing orthotopic liver transplantation. Am J Gastroenterol (2001) 1.08
Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy. Liver Transpl (2004) 1.01
Leptin-leptin receptor are involved in angiogenesis in human hepatocellular carcinoma. Peptides (2008) 0.97
Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase. BMC Cancer (2010) 0.96
Increased early morbidity and mortality with acceptable long-term function in severely obese patients undergoing liver transplantation. Clin Transplant (1999) 0.92
Liver transplantation in the morbidly obese. J Clin Anesth (1996) 0.92
Preoperative computed tomography measurements of pancreatic steatosis and visceral fat: prognostic markers for dissemination and lethality of pancreatic adenocarcinoma. HPB (Oxford) (2011) 0.88
Surgical morbidity in severely obese liver transplant recipients - a single Canadian Centre Experience. Ann Hepatol (2009) 0.80
Liver transplantation in patients with severe obesity. Transplantation (1994) 0.80
Student quality-of-life declines during third year surgical clerkship. J Surg Res (2007) 2.05
Important surgical considerations in the management of renal cell carcinoma (RCC) with inferior vena cava (IVC) tumour thrombus. BJU Int (2012) 1.76
Laparoendoscopic single site cholecystectomy: the first 100 patients. Am Surg (2009) 1.72
Laparoendoscopic single site (LESS) cholecystectomy. J Gastrointest Surg (2008) 1.66
Lack of Clostridium difficile infection in patients treated with rifaximin for hepatic encephalopathy: a retrospective analysis. J Clin Gastroenterol (2013) 1.48
Does Barrett's esophagus impact outcome after laparoscopic Nissen fundoplication? Am J Surg (2006) 1.44
Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology (2006) 1.38
A retrospective review of liver transplant patients treated with sirolimus from a single center: an analysis of sirolimus-related complications. Transplantation (2004) 1.30
Matrix metalloproteinases and their role in pancreatic cancer: a review of preclinical studies and clinical trials. Ann Surg Oncol (2002) 1.27
Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors. Ann Surg Oncol (2006) 1.23
Symptoms and antireflux medication use following laparoscopic Nissen fundoplication: outcome at 1 and 4 years. JSLS (2003) 1.21
Access to liver transplantation in the MELD era: role of ethnicity and insurance. Dig Dis Sci (2008) 1.21
Primary hepatic non-Hodgkin's lymphomas: case report and review of the literature. Am J Gastroenterol (2003) 1.19
Impact of geographic location on access to liver transplantation among ethnic minorities. Transplantation (2008) 1.12
TIMP-1 overexpression in pancreatic cancer attenuates tumor growth, decreases implantation and metastasis, and inhibits angiogenesis. J Surg Res (2002) 1.08
Herpes simplex virus hepatitis - it's high time we consider empiric treatment. J Gastrointestin Liver Dis (2011) 1.08
Surgical management of early-stage pancreatic cancer. Cancer Control (2004) 1.07
Public perception of LESS surgery and NOTES. J Gastrointest Surg (2011) 1.05
Fibrinogen gamma overexpression in pancreatic cancer identified by large-scale proteomic analysis of serum samples. Cancer Res (2006) 1.05
Patients' perceptions of laparoendoscopic single-site surgery: the cosmetic effect. Am J Surg (2012) 1.05
Defining the role of the epidermal growth factor receptor in pancreatic cancer grown in vitro. Am J Surg (2003) 1.04
The natural history of resected pancreatic cancer without adjuvant chemotherapy. Am Surg (2010) 1.02
Stage does not predict survival after resection of hilar cholangiocarcinomas promoting an aggressive operative approach. Am J Surg (2005) 0.99
Twenty-millimeter laparoscopic cholecystectomy: fewer ports results in less pain, shorter hospitalization, and faster recovery. Am Surg (2005) 0.98
Nonalcoholic fatty liver disease epidemic and its implications for liver transplantation. Transplantation (2013) 0.96
Ethnic variations in chronic liver diseases. Dig Dis Sci (2007) 0.95
Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy. Am Surg (2002) 0.94
Identification of molecular markers specific for pancreatic neuroendocrine tumors by genetic profiling of core biopsies. Ann Surg Oncol (2004) 0.93
Early results of laparoscopic Heller myotomy do not necessarily predict long-term outcome. Am J Surg (2004) 0.92
Liver transplantation in the ethnic minority population: challenges and prospects. Dig Dis Sci (2009) 0.92
Predicting the probable outcome of treatment in HCV patients. Therap Adv Gastroenterol (2009) 0.92
Surgical shunting versus transjugular intrahepatic portasystemic shunting for bleeding varices resulting from portal hypertension and cirrhosis: a meta-analysis. Am Surg (2010) 0.92
Selective application of fundoplication during laparoscopic heller myotomy ensures favorable outcomes. Surg Laparosc Endosc Percutan Tech (2002) 0.90
The "learning curve" in videoscopic Heller myotomy. JSLS (2002) 0.90
Transduodenal ampullectomy for ampullary adenomas: a safe and effective procedure with long-term salutary outcomes. Am Surg (2014) 0.89
Videoscopic Heller myotomy with intraoperative endoscopy promotes optimal outcomes. JSLS (2002) 0.89
Reproductive factors and risk of pancreatic cancer in women: a review of the literature. Ann Epidemiol (2009) 0.88
Liver transplantation trends for older recipients: regional and ethnic variations. Transplantation (2008) 0.88
Preoperative intervention does not affect esophageal muscle histology or patient outcomes in patients undergoing laparoscopic Heller myotomy. J Gastrointest Surg (2003) 0.87
Defining the learning curve of laparoendoscopic single-site Heller myotomy. Am Surg (2013) 0.87
Severe hepatotoxicity associated with the use of weight loss diet supplements containing ma huang or usnic acid. J Hepatol (2004) 0.87
Acquired hyperplastic gastric polyps in solid organ transplant patients. Am J Gastroenterol (2002) 0.86
Combination therapy in liver transplant recipients with hepatitis B virus without hepatitis B immune globulin. Dig Dis Sci (2007) 0.86
Perspectives of third-year medical students toward their surgical clerkship and a surgical career. J Surg Res (2007) 0.86
Laparoendoscopic single-site Heller myotomy with anterior fundoplication for achalasia. Surg Endosc (2011) 0.85
Nonalcoholic Fatty Liver Disease Epidemic and Its Implications for Liver Transplantation. Transplantation (2013) 0.85
Uncovering the truth about covered stents: is there a difference between covered versus uncovered stents with transjugular intrahepatic portosystemic shunts? Am J Surg (2011) 0.85
Update on the management of cirrhosis - focus on cost-effective preventative strategies. Clinicoecon Outcomes Res (2013) 0.84
Difficult myotomy is not determined by preoperative therapy and does not impact outcome. JSLS (2007) 0.84
Durability of rifaximin response in hepatic encephalopathy. J Clin Gastroenterol (2012) 0.84
Seroepidemiology of hepatitis A virus in Kuwait. World J Gastroenterol (2009) 0.84
Managing chronic hepatitis C in the difficult-to-treat patient. Liver Int (2007) 0.84
Laparoscopic Heller myotomy for achalasia: results after 10 years. Surg Endosc (2009) 0.84
EGF receptor antagonism improves survival in a murine model of pancreatic adenocarcinoma. J Surg Res (2006) 0.83
Laparo-endoscopic single-site (LESS) cholecystectomy with epidural vs. general anesthesia. Surg Endosc (2012) 0.82
Differential expression of the Tie-2 receptor and its ligands in human pancreatic tumors. J Am Coll Surg (2004) 0.82
In-continuity hepatic resection for advanced hilar cholangiocarcinoma. Am J Surg (2004) 0.82
Adult onset urea cycle disorder in a patient with presumed hepatic encephalopathy. J Clin Gastroenterol (2008) 0.82
Access for laparoendoscopic single site surgery. Diagn Ther Endosc (2010) 0.82
Does concomitant anterior fundoplication promote dysphagia after laparoscopic Heller myotomy? Am Surg (2008) 0.81
TIMP-1 antisense gene transfection attenuates the invasive potential of pancreatic cancer cells in vitro and inhibits tumor growth in vivo. Am J Surg (2005) 0.81
A Single Institution's First 100 Patients Undergoing Laparoscopic Anti-Reflux Fundoplications: Where Are They 20 Years Later? Am Surg (2015) 0.81
Obesity is not a contraindication to laparoscopic Nissen fundoplication. J Gastrointest Surg (2005) 0.80
Laparoscopic Heller myotomy with anterior fundoplication ameliorates symptoms of achalasia in pediatric patients. J Am Coll Surg (2007) 0.80
Esophagography predicts favorable outcomes after laparoscopic Nissen fundoplication for patients with esophageal dysmotility. J Am Coll Surg (2005) 0.80
Prognostic significance of new onset ascites in patients with pancreatic cancer. World J Surg Oncol (2006) 0.80
Causes of dissatisfaction after laparoscopic fundoplication: the impact of new symptoms, recurrent symptoms, and the patient experience. Surg Endosc (2013) 0.80
Insertion of intracranial pressure monitors in fulminant hepatic failure patients: early experience using recombinant factor VII. Neurosurgery (2010) 0.79
Transoral incisionless fundoplication: is it as safe and efficacious as a Nissen or Toupet fundoplication? Am Surg (2014) 0.79
Impact of hospital and surgeon volumes in the management of complicated portal hypertension: review of a statewide database in Florida. Am Surg (2010) 0.78
The learning curve of laparoendoscopic single-Site (LESS) fundoplication: definable, short, and safe. JSLS (2013) 0.78
Sirolimus therapy in orthotopic liver transplant (OLT) recipients with acute renal insufficiency. Dig Dis Sci (2005) 0.78
MMP-2 and TIMP-1 are derived from, not in response to, pancreatic cancer. J Surg Res (2002) 0.78
Factors contributing to health disparities in liver transplantation in a Hispanic population. P R Health Sci J (2012) 0.77
Prospective, randomized, multi-center trial of antibody induction therapy in simultaneous pancreas-kidney transplantation. Am J Transplant (2003) 0.77
Survival after pancreatectomy for pancreatic adenocarcinoma is not impacted by performance status. Am J Surg (2012) 0.77
Management of recurrent viral hepatitis B and C after liver transplantation. Curr Gastroenterol Rep (2006) 0.77
Differential gene expression in patients genetically predisposed to pancreatic cancer. J Surg Res (2006) 0.77
Outcomes after transjugular intrahepatic portosystemic stent shunt: a "bridge" to nowhere. Am J Surg (2013) 0.77
Assessment of pancreatic neoplasms: review of biopsy techniques. J Gastrointest Surg (2007) 0.77
TNFalpha gene delivery therapy for solid tumors. Expert Opin Biol Ther (2010) 0.76
"Redo" fundoplications: satisfactory symptomatic outcomes with higher cost of care. J Surg Res (2007) 0.76
Rifaximin for the treatment of recurrent Clostridium difficile infection after liver transplantation: A case series. Liver Transpl (2010) 0.76
Normal lower esophageal sphincter pressure and length does not impact outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg (2007) 0.76
Late results after laparoscopic fundoplication denote durable symptomatic relief of gastroesophageal reflux disease. Am J Surg (2013) 0.76
Therapeutic Success of Rifaximin for Clostridium difficile Infection Refractory to Metronidazole and Vancomycin. Case Rep Gastroenterol (2010) 0.75
Margin status impacts survival after pancreaticoduodenectomy but negative margins should not be pursued. Am Surg (2014) 0.75
Pancreatic infections. Arch Surg (2011) 0.75
Can sorafenib increase survival for recurrent hepatocellular carcinoma after liver transplantation? A pilot study. Am Surg (2014) 0.75
Early use of renal-sparing agents in liver transplantation: a closer look. Liver Transpl (2013) 0.75
Rhabdomylysis transference during liver transplantation. Transplantation (2006) 0.75
Liver transplantation trends and survival in the Asian population. Transplantation (2009) 0.75
Age and Achalasia: How Does Age Affect Patient Presentation, Hospital Course, and Surgical Outcomes? Am Surg (2017) 0.75
Combined Robotic Colon and Liver Resection for Synchronous Colorectal Liver Metastasis: A Movement Toward a New Gold Standard. Am Surg (2019) 0.75
Successful treatment with thalidomide in a liver transplant recipient with giant esophageal ulcers. Liver Transpl (2006) 0.75